Vir Biotechnology, Inc. VIR Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s increase (decrease) in prepaid expense and other assets?
- Vir Biotechnology, Inc. (VIR) reported increase (decrease) in prepaid expense and other assets of -$382K in Q1 2026.
- How has Vir Biotechnology, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
- Vir Biotechnology, Inc.'s increase (decrease) in prepaid expense and other assets increased by 92.4% year-over-year, from -$5.06M to -$382K.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.